[Beta blockers in heart failure. Experiences and recommendations for clinical use. ANMCO-Area Heart Failure].
Sinagra
G
G
ANMCO-Area Scompenso Cardiaco, Firenze.
Boccanelli
A
A
Camerini
F
F
Gavazzi
A
A
Gronda
E
E
Maggioni
A P
AP
Opasich
C
C
Rapezzi
C
C
Scherillo
M
M
Tavazzi
L
L
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D017298:Bisoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D002227:Carbazoles / Q000008:administration & dosage / Q000627:therapeutic use; D000077261:Carvedilol; D018849:Controlled Clinical Trials as Topic; D005500:Follow-Up Studies; D006333:Heart Failure / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D006801:Humans; D008790:Metoprolol / Q000008:administration & dosage / Q000627:therapeutic use; D011412:Propanolamines / Q000008:administration & dosage / Q000627:therapeutic use; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D011412:Propanolamines; D014665:Vasodilator Agents; D000077261:Carvedilol; D008790:Metoprolol; D017298:Bisoprolol
Betabloccanti nello scompenso cardiaco. Esperienze e suggerimenti per l'impiego clinico. ANMCO-Area Scompenso Cardiaco.